musculoskeletal disease

News

Kaia Health has raised a further $75m to expand its AI-based treatment for Musculoskeletal (MSK) and chronic obstructive pulmonary disease (COPD).

News

ITM's first attempt to score FDA approval for one of its radiopharma therapies has been knocked back by the agency.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.